Improved antigen presentation expands the power of cancer immunotherapy, a new study shows

A New UChicago collaboration demonstrates that the tumor control rate in mice can be boosted from 40 percent up to nearly 100 percent through nullifying protein YTHDF1, opening up a new approach to treatment of cancer in patients who do not respond well to checkpoint inhibitors.